INDO US BIOTECH LTD Intrinsic Value
INDOUS · FMCG · Current price ₹87.28
Is INDO US BIOTECH LTD undervalued?
DocStoX estimates the fair value of INDO US BIOTECH LTD at ₹79 per share, versus the current market price of ₹87. That puts the stock about -10.1% above our fair-value estimate, which we read as "Fairly Valued". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹47), Relative P/E (₹134), Graham floor (₹92). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹47 (bear) to ₹79 (base) to ₹134 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹87 versus an intrinsic value of ₹79, INDO US BIOTECH LTD currently offers -10.1% of negative margin (i.e. a premium).
More on INDO US BIOTECH LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.